UniProt ID | ZFAN5_HUMAN | |
---|---|---|
UniProt AC | O76080 | |
Protein Name | AN1-type zinc finger protein 5 | |
Gene Name | ZFAND5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 213 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Involved in protein degradation via the ubiquitin-proteasome system. May act by anchoring ubiquitinated proteins to the proteasome. Plays a role in ubiquitin-mediated protein degradation during muscle atrophy. Plays a role in the regulation of NF-kappa-B activation and apoptosis. Inhibits NF-kappa-B activation triggered by overexpression of RIPK1 and TRAF6 but not of RELA. Inhibits also tumor necrosis factor (TNF), IL-1 and TLR4-induced NF-kappa-B activation in a dose-dependent manner. Overexpression sensitizes cells to TNF-induced apoptosis. Is a potent inhibitory factor for osteoclast differentiation.. | |
Protein Sequence | MAQETNQTPGPMLCSTGCGFYGNPRTNGMCSVCYKEHLQRQQNSGRMSPMGTASGSNSPTSDSASVQRADTSLNNCEGAAGSTSEKSRNVPVAALPVTQQMTEMSISREDKITTPKTEVSEPVVTQPSPSVSQPSTSQSEEKAPELPKPKKNRCFMCRKKVGLTGFDCRCGNLFCGLHRYSDKHNCPYDYKAEAAAKIRKENPVVVAEKIQRI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAQETNQTPGPM ---CCCCCCCCCCCE | 22.13 | 24043423 | |
8 | Phosphorylation | MAQETNQTPGPMLCS CCCCCCCCCCCEECC | 32.08 | 25159151 | |
15 | Phosphorylation | TPGPMLCSTGCGFYG CCCCEECCCCCCCCC | 24.71 | 24043423 | |
16 | Phosphorylation | PGPMLCSTGCGFYGN CCCEECCCCCCCCCC | 35.18 | 24043423 | |
21 | Phosphorylation | CSTGCGFYGNPRTNG CCCCCCCCCCCCCCC | 10.98 | 24043423 | |
35 | Ubiquitination | GMCSVCYKEHLQRQQ CCCHHHHHHHHHHHH | 33.27 | - | |
44 | Phosphorylation | HLQRQQNSGRMSPMG HHHHHHHCCCCCCCC | 24.36 | 23401153 | |
48 | Phosphorylation | QQNSGRMSPMGTASG HHHCCCCCCCCCCCC | 15.46 | 29255136 | |
52 | Phosphorylation | GRMSPMGTASGSNSP CCCCCCCCCCCCCCC | 16.05 | 29255136 | |
54 | Phosphorylation | MSPMGTASGSNSPTS CCCCCCCCCCCCCCC | 42.46 | 29255136 | |
56 | Phosphorylation | PMGTASGSNSPTSDS CCCCCCCCCCCCCCC | 31.47 | 29255136 | |
58 | Phosphorylation | GTASGSNSPTSDSAS CCCCCCCCCCCCCHH | 31.11 | 29255136 | |
60 | Phosphorylation | ASGSNSPTSDSASVQ CCCCCCCCCCCHHHH | 45.01 | 29255136 | |
61 | Phosphorylation | SGSNSPTSDSASVQR CCCCCCCCCCHHHHC | 32.71 | 29255136 | |
63 | Phosphorylation | SNSPTSDSASVQRAD CCCCCCCCHHHHCCC | 23.39 | 29255136 | |
65 | Phosphorylation | SPTSDSASVQRADTS CCCCCCHHHHCCCCC | 23.80 | 23927012 | |
71 | Phosphorylation | ASVQRADTSLNNCEG HHHHCCCCCCCCCCC | 33.84 | 25627689 | |
72 | Phosphorylation | SVQRADTSLNNCEGA HHHCCCCCCCCCCCC | 29.64 | 25262027 | |
86 | Ubiquitination | AAGSTSEKSRNVPVA CCCCCCHHHCCCCEE | 55.25 | 21906983 | |
98 | Phosphorylation | PVAALPVTQQMTEMS CEEEEECCHHHHHCC | 15.90 | 20058876 | |
102 | Phosphorylation | LPVTQQMTEMSISRE EECCHHHHHCCCCCC | 24.97 | 27251275 | |
105 | Phosphorylation | TQQMTEMSISREDKI CHHHHHCCCCCCCCC | 15.92 | 27251275 | |
107 | Phosphorylation | QMTEMSISREDKITT HHHHCCCCCCCCCCC | 23.47 | 27251275 | |
113 | Phosphorylation | ISREDKITTPKTEVS CCCCCCCCCCCCCCC | 42.67 | 28348404 | |
114 | Phosphorylation | SREDKITTPKTEVSE CCCCCCCCCCCCCCC | 26.68 | 28348404 | |
117 | Phosphorylation | DKITTPKTEVSEPVV CCCCCCCCCCCCCEE | 42.71 | 28348404 | |
120 | Phosphorylation | TTPKTEVSEPVVTQP CCCCCCCCCCEECCC | 29.92 | 28348404 | |
125 | Phosphorylation | EVSEPVVTQPSPSVS CCCCCEECCCCCCCC | 34.69 | 22199227 | |
128 | Phosphorylation | EPVVTQPSPSVSQPS CCEECCCCCCCCCCC | 21.71 | 21815630 | |
130 | Phosphorylation | VVTQPSPSVSQPSTS EECCCCCCCCCCCCC | 38.44 | 30576142 | |
139 | Phosphorylation | SQPSTSQSEEKAPEL CCCCCCCCHHHCCCC | 47.71 | 28464451 | |
148 | Ubiquitination | EKAPELPKPKKNRCF HHCCCCCCCCCCCEE | 80.32 | 21906983 | |
180 | Phosphorylation | LFCGLHRYSDKHNCP EEHHCCCCCCCCCCC | 15.52 | - | |
181 | Phosphorylation | FCGLHRYSDKHNCPY EHHCCCCCCCCCCCC | 39.89 | - | |
183 | Acetylation | GLHRYSDKHNCPYDY HCCCCCCCCCCCCCH | 30.67 | 27452117 | |
183 | Ubiquitination | GLHRYSDKHNCPYDY HCCCCCCCCCCCCCH | 30.67 | - | |
188 | Phosphorylation | SDKHNCPYDYKAEAA CCCCCCCCCHHHHHH | 33.82 | - | |
190 | Phosphorylation | KHNCPYDYKAEAAAK CCCCCCCHHHHHHHH | 13.27 | - | |
191 | Ubiquitination | HNCPYDYKAEAAAKI CCCCCCHHHHHHHHH | 36.53 | - | |
197 | Acetylation | YKAEAAAKIRKENPV HHHHHHHHHHHHCCE | 38.01 | 25953088 | |
197 | Ubiquitination | YKAEAAAKIRKENPV HHHHHHHHHHHHCCE | 38.01 | - | |
200 | Ubiquitination | EAAAKIRKENPVVVA HHHHHHHHHCCEEEE | 66.37 | - | |
209 | Ubiquitination | NPVVVAEKIQRI--- CCEEEEEECCCC--- | 34.11 | - | |
209 | Acetylation | NPVVVAEKIQRI--- CCEEEEEECCCC--- | 34.11 | 23954790 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZFAN5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZFAN5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NEMO_HUMAN | IKBKG | physical | 14754897 | |
TRAF6_HUMAN | TRAF6 | physical | 14754897 | |
PSMD6_HUMAN | PSMD6 | physical | 16424905 | |
UBC_HUMAN | UBC | physical | 21923101 | |
SQSTM_HUMAN | SQSTM1 | physical | 21923101 | |
A4_HUMAN | APP | physical | 21832049 | |
CETN1_HUMAN | CETN1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND MASSSPECTROMETRY. |